HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) — Nuo Therapeutics, Inc. AURX (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, is pleased to announce that Wound Care Advantage (WCA), the nation’s leading wound care consulting firm has added…Read More
Nuo Therapeutics Aurix System Added To Wound Care Formulary Of Wound Care Advantage Nuo Therapeutics OTCAURX
